Haoyue Xiang

Title: Haoyue Xiang: Innovator in Pharmaceutical Compounds

Introduction

Haoyue Xiang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific pathways in cancer treatment. His innovative work has the potential to lead to new therapeutic options for various diseases.

Latest Patents

Haoyue Xiang holds 1 patent for his invention titled "7-site substituted pyrrole triazine compounds or pharmaceutically acceptable salts thereof, and preparation method thereof and uses thereof." This patent describes compounds that exhibit good PI3K inhibitory activity, effectively inhibiting the activity of PI3K kinase. The introduction of the 7-position group enhances the pharmacokinetic properties, such as bioavailability. These compounds demonstrate high selectivity and strong inhibitory activity on PI3Kδ, making them promising candidates for treating diseases related to the PI3K pathway, especially in anti-cancer therapies.

Career Highlights

Haoyue Xiang is affiliated with the Chinese Academy of Sciences, where he conducts his research and development work. His focus on innovative pharmaceutical compounds has positioned him as a key figure in the field. His research aims to optimize and screen these compounds for potential development into new anti-tumor drugs.

Collaborations

Haoyue Xiang collaborates with notable colleagues, including Chunhao Yang and Linghua Meng. Their combined expertise contributes to the advancement of research in pharmaceutical innovations.

Conclusion

Haoyue Xiang's work in developing novel pharmaceutical compounds showcases his dedication to advancing cancer treatment options. His innovative contributions are expected to have a significant impact on the field of medicine.